Ground Swell Capital’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
BI
SCM
APM
OFM
Ground Swell Capital's IMUX Position: Q1 2025 in Review
Ground Swell Capital sold out of Immunic (IMUX) in Q1 2025, closing a stake of 1,136 shares — an estimated $11.4K sold.
Ground Swell Capital first reported a position in IMUX in Q4 2024 and held it in 1 quarter. The position peaked at $11.4K in Q4 2024. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.
- Ground Swell Capital reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
- Ground Swell Capital sold 1,136 Immunic shares in Q1 2025, an estimated $11.4K.
- Ground Swell Capital first reported a position in Immunic in Q4 2024 and held it in 1 quarter.
- Ground Swell Capital's Immunic position peaked at $11.4K in Q4 2024.
- 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.
Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.